Science ❯Pharmaceuticals

Drug Development

Public Health Drug Approval Drug Pricing Biomedical Engineering Medical Innovations Research and Development Health Equity Pharmacology Drug Delivery Drug Development

FDA Approves Yeztugo, First Twice-Yearly Shot Preventing HIV

Gilead’s list price of $28,218 draws criticism from advocates urging lower costs to extend availability to poorer nations.

MIT Researchers Unveil Injectable Microcrystal System for Long-Term Drug Delivery